|Measuring Intervention Outcomes and Evaluating Quality of Programs for Individuals With Autism Spectrum Disorder: A Discussion
|Saturday, May 26, 2018
|4:00 PM–4:50 PM
|Manchester Grand Hyatt, Seaport Ballroom F
|Area: AUT/PRA; Domain: Service Delivery
|CE Instructor: Sara Gershfeld Litvak, M.A.
|Chair: Sara Gershfeld Litvak (Behavioral Health Center of Excellence)
|HANNA C. RUE (Autism Spectrum Therapies)
|THOMAS J. ZWICKER (ZABA Therapy; Behavioral Health Center of Excellence)
|YAGNESH VADGAMA (Magellan Healthcare)
Intervention outcomes in ABA are most commonly measured through single-case research designs where the effects of individualized interventions are evaluated. Given the countless combinations of behaviors that meet the diagnostic criteria for ASD, it is of little surprise that consensus has not been reached on how to measure intervention outcomes. The lack of consensus makes it difficult to evaluate the overall quality of organizations' clinical programs. However, BCBA's are experiencing more pressure than ever before to demonstrate intervention outcomes for insurance reimbursement and allocation of public funds. Various methods to measure intervention outcomes and quality of programs will be discussed.
|Instruction Level: Intermediate
This panel is appropriate for clinical staff who are interested in identifying the methodology for reporting aggregate client outcomes to stakeholders. BCBA's, Senior Leadership, or Researchers are welcome.
|Learning Objectives: Attendees will learn to identify appropriate methodology for reporting client outcomes at the micro or macro level. Challenges will be discussed related to client outcome measurement, single subject design and stake holder responsibilities.
|Keyword(s): group design, outcome analysis, quality assurance, sustainable programming